Health Care & Life Sciences » Pharmaceuticals » Merck & Co. | Merck and Co top-selling drugs revenue 2017

Merck & Co.'s top-selling drugs 2014-2017

Top selling products of Merck & Co. based on revenue from 2014 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays Merck and Co.'s top selling drugs from 2011 to 2017. Merck & Co. is one of the biggest pharmaceutical companies in the world. The company is headquartered in Whitehouse Station, New Jersey. In 2016, Merck's top product Januvia generated around 5.5 billion USD of revenue. Januvia (sitagliptin) is a antidiabetic drug, and one of Merck's major products since 2007.

Keytruda	55	566	1402	3809
Januvia	3931	3863	3908	3737
Gardasil	1738	1908	2173	2308
Janumet	2071	2151	2201	2158
ProQuad	1394	1505	1640	1676
Zepatier			555	1660
Zetia	2650	2526	2560	1344
Isentress	1673	1511	1387	1204
Remicade	2372	1794	1268	837
Simponi		690	766	819

Merck & Co.'s top-selling drugs 2014-2017

StatInvestor